HomeNewswire

Newswire

Biotech Stocks Poised for Q3 Earnings Surprises

Biotech Stocks Poised for Q3 Earnings Surprises

November 5, 2026

Corcept Therapeutics Reports Strong Q3 Earnings and Revenue Growth

Corcept Therapeutics Reports Strong Q3 Earnings and Revenue Growth

November 5, 2026

Teva Exceeds Q3 Expectations, Raises 2026 Revenue Forecast

Teva Exceeds Q3 Expectations, Raises 2026 Revenue Forecast

November 5, 2026

Argan Shares Decline Despite Strong Earnings Report

Argan Shares Decline Despite Strong Earnings Report

November 5, 2026

Bloom Energy Increases Full-Year Forecast After Revenue Surge

Bloom Energy Increases Full-Year Forecast After Revenue Surge

November 5, 2026

CRISPR Therapeutics Reports Wider Q3 Loss, Surpasses Revenue Estimates

CRISPR Therapeutics Reports Wider Q3 Loss, Surpasses Revenue Estimates

November 4, 2026

Biopreservation Market to Reach $10.7 Billion by 2032

Biopreservation Market to Reach $10.7 Billion by 2032

November 4, 2026

Evaluating Bitmine Immersion Technologies’ Market Valuation

Evaluating Bitmine Immersion Technologies’ Market Valuation

November 4, 2026

Vestwell’s Growth Strategy Highlighted by CEO at NYSE Summit

Vestwell’s Growth Strategy Highlighted by CEO at NYSE Summit

November 4, 2026

Valero Acquires Houston Refinery, Plans 165,000 BPD Restart

Valero Acquires Houston Refinery, Plans 165,000 BPD Restart

November 4, 2026

« 1 2 3 4 … 8 »